We observed upregulation of PD-L1 and IDO transcripts from our B7-H3 knockdown tumor RNA-seq (Supplementary Data 1), which is of interest because both genes have been demonstrated to play a critical role in primary resistance to PD-L1/PD-1 immunotherapy66,67. The gene discussed is CD276; the disease is neoplasm.